Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal:	Mirza, Maisa Tasnim
Autres auteurs:	Jamiruddin, Dr. Mohd. Raeed
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
Accès en ligne:	http://hdl.handle.net/10361/18147

Documents similaires

Breast cancer awareness seminars
par: Anwer Khan Modern Medical College
Publié: (2016)

Recent advancement on breast cancer detection and treatment
par: Rahman, Sanjida
Publié: (2023)

Natural products and their combinatory effects in breast cancer treatment
par: Siddique, Md. Ayman
Publié: (2021)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
par: Shobnam, Sohana
Publié: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
par: Akter, Honufa
Publié: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
par: Iqbal, Mohammad Shamim, et autres
Publié: (2017)

The impact of breast cancer on women’s lives in Bangladesh
par: Mobashera, Tayeeba Tum
Publié: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

A review on triple-negative breast cancer and its potential treatment
par: Niasa, Jannatul Ferdous
Publié: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
par: Araf, Faiaz Fahim
Publié: (2024)

Machine learning as an indicator for breast cancer prediction
par: Shadman, Tahsin Mohammed, et autres
Publié: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
par: Nuha, Nabiha Tahsin
Publié: (2024)

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
par: Lamia
Publié: (2020)

Early detection of breast cancer using machine learning
par: Fuad, Wasi Mohammad
Publié: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
par: Hossain, Mohammad Sorowar, et autres
Publié: (2017)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
par: Parvin, Salma, et autres
Publié: (2016)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
par: Oishy, Jannatun Noor
Publié: (2024)

Breast cancer prediction using different machine learning models
par: Khandker Al- Muhaimin, et autres
Publié: (2020)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
par: Hasan, Sakib
Publié: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
par: Monayem, Kazi Fahim
Publié: (2024)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
par: Haque, Fariha
Publié: (2023)

Machine learning In breast cancer prognosis and prediction
par: Chowdhury, Shah Abul Hasnat, et autres
Publié: (2023)

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
par: Ahmad, Sheikh Shafin
Publié: (2021)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
par: Rahman, Sanjida
Publié: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)

Immunotherapy in the treatment of renal cancer
par: Shimu, Sumaya
Publié: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
par: Chowdhury, Maisha Mosharrat
Publié: (2018)

Cancer risk factors: a critical review
par: Tabassum, Tahsina
Publié: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
par: Nawar, Anika
Publié: (2019)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
par: Al Mamun, Rafsan, et autres
Publié: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
par: Abir, Shifaty Nur
Publié: (2024)

Targeting BRAFV600E in the treatment of CRC
par: Roja, Mashwiyat Samrin
Publié: (2024)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)